Mayer B - Search Results

1

Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.

Schrammel A, Behrends S, Schmidt K, Koesling D, Mayer B. Schrammel A, et al. Among authors: mayer b. Mol Pharmacol. 1996 Jul;50(1):1-5. Mol Pharmacol. 1996. PMID: 8700100

2

Consumption of nitric oxide by endothelial cells: evidence for the involvement of a NAD(P)H-, flavin- and heme-dependent dioxygenase reaction.

Schmidt K, Mayer B. Schmidt K, et al. Among authors: mayer b. FEBS Lett. 2004 Nov 5;577(1-2):199-204. doi: 10.1016/j.febslet.2004.10.010. FEBS Lett. 2004. PMID: 15527785 Free article.

3

Effects of nitroglycerin/L-cysteine on soluble guanylate cyclase: evidence for an activation/inactivation equilibrium controlled by nitric oxide binding and haem oxidation.

Gorren AC, Russwurm M, Kollau A, Koesling D, Schmidt K, Mayer B. Gorren AC, et al. Among authors: mayer b. Biochem J. 2005 Sep 1;390(Pt 2):625-31. doi: 10.1042/BJ20050565. Biochem J. 2005. PMID: 15907191 Free PMC article.

4

Bioactivation of nitroglycerin by ascorbate.

Kollau A, Beretta M, Gorren AC, Russwurm M, Koesling D, Schmidt K, Mayer B. Kollau A, et al. Among authors: mayer b. Mol Pharmacol. 2007 Jul;72(1):191-6. doi: 10.1124/mol.107.035642. Epub 2007 Apr 19. Mol Pharmacol. 2007. PMID: 17446267

5

Inactivation of soluble guanylate cyclase by stoichiometric S-nitrosation.

Mayer B, Kleschyov AL, Stessel H, Russwurm M, Münzel T, Koesling D, Schmidt K. Mayer B, et al. Mol Pharmacol. 2009 Apr;75(4):886-91. doi: 10.1124/mol.108.052142. Epub 2008 Dec 29. Mol Pharmacol. 2009. PMID: 19114587

6

Mechanisms underlying activation of soluble guanylate cyclase by the nitroxyl donor Angeli's salt.

Zeller A, Wenzl MV, Beretta M, Stessel H, Russwurm M, Koesling D, Schmidt K, Mayer B. Zeller A, et al. Among authors: mayer b. Mol Pharmacol. 2009 Nov;76(5):1115-22. doi: 10.1124/mol.109.059915. Epub 2009 Aug 31. Mol Pharmacol. 2009. PMID: 19720727

7

Bioactivation of pentaerythrityl tetranitrate by mitochondrial aldehyde dehydrogenase.

Griesberger M, Kollau A, Wölkart G, Wenzl MV, Beretta M, Russwurm M, Koesling D, Schmidt K, Gorren AC, Mayer B. Griesberger M, et al. Among authors: mayer b. Mol Pharmacol. 2011 Mar;79(3):541-8. doi: 10.1124/mol.110.069138. Epub 2010 Dec 14. Mol Pharmacol. 2011. PMID: 21156756

8

Site-directed mutagenesis of aldehyde dehydrogenase-2 suggests three distinct pathways of nitroglycerin biotransformation.

Wenzl MV, Beretta M, Griesberger M, Russwurm M, Koesling D, Schmidt K, Mayer B, Gorren AC. Wenzl MV, et al. Among authors: mayer b. Mol Pharmacol. 2011 Aug;80(2):258-66. doi: 10.1124/mol.111.071704. Epub 2011 May 2. Mol Pharmacol. 2011. PMID: 21536753

9

Tetrahydrobiopterin protects soluble guanylate cyclase against oxidative inactivation.

Schmidt K, Neubauer A, Kolesnik B, Stasch JP, Werner ER, Gorren AC, Mayer B. Schmidt K, et al. Among authors: mayer b. Mol Pharmacol. 2012 Sep;82(3):420-7. doi: 10.1124/mol.112.079855. Epub 2012 May 30. Mol Pharmacol. 2012. PMID: 22648973

10

Potent inhibition of aldehyde dehydrogenase-2 by diphenyleneiodonium: focus on nitroglycerin bioactivation.

Neubauer R, Neubauer A, Wölkart G, Schwarzenegger C, Lang B, Schmidt K, Russwurm M, Koesling D, Gorren AC, Schrammel A, Mayer B. Neubauer R, et al. Among authors: mayer b. Mol Pharmacol. 2013 Sep;84(3):407-14. doi: 10.1124/mol.113.086835. Epub 2013 Jun 21. Mol Pharmacol. 2013. PMID: 23793290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,636 results

Search Page

Filters